ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $158 | -29.5% | 34,335 | -1.2% | 0.00% | 0.0% |
Q2 2023 | $224 | -18.5% | 34,743 | -4.6% | 0.00% | 0.0% |
Q1 2023 | $275 | -37.2% | 36,418 | -15.7% | 0.00% | -50.0% |
Q4 2022 | $438 | -99.9% | 43,218 | -4.3% | 0.00% | -33.3% |
Q3 2022 | $447,000 | -3.7% | 45,172 | +3.6% | 0.00% | +50.0% |
Q2 2022 | $464,000 | +1.3% | 43,607 | -7.2% | 0.00% | 0.0% |
Q1 2022 | $458,000 | -30.0% | 46,968 | +2.6% | 0.00% | -33.3% |
Q4 2021 | $654,000 | -23.1% | 45,763 | +7.9% | 0.00% | -25.0% |
Q3 2021 | $850,000 | +43.8% | 42,408 | +57.8% | 0.00% | +33.3% |
Q2 2021 | $591,000 | – | 26,882 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |